Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.

Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety / Dahl, Oe; Eriksson, Bi; Agnelli, Giancarlo; Cohen, At; Mouret, P; Rosencher, N; Panfilov, S; Bylock, A; Andersson, M.. - In: CLINICAL DRUG INVESTIGATION. - ISSN 1173-2563. - 25(2005).



Titolo: Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.
Autori: 
AGNELLI, Giancarlo
mostra contributor esterni 
Data di pubblicazione: 2005
Rivista: 
CLINICAL DRUG INVESTIGATION  
Handle: http://hdl.handle.net/11391/918273
Appare nelle tipologie:1.1 Articolo in rivista

File in questo prodotto:
Non ci sono file associati a questo prodotto.
Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11391/918273
  • Citazioni
  • PubMed Central ND
  • Scopus
  • WOS

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2021